Society For Translational Oncology

The Society for Translational Oncology (STO) is a 501(c)(3) non-profit organization based in Durham, North Carolina. The organization is relatively small, with a staff of four employees. STO generates annual revenue of $2.5 million. STO's mission is to improve patient care by fostering the development and clinical application of novel cancer therapies. They aim to bridge the gap between drug discovery and patient access by providing educational programs for physicians and other healthcare professionals. STO's commitment to translational research and education extends to fellowships in both cancer and infectious diseases. The organization has particularly focused on infectious diseases in response to the COVID-19 pandemic, supporting the development and distribution of vaccines and treatments. A key aspect of STO's work is its dedication to diversity, inclusivity, and equity in all its programs. This commitment ensures that their efforts benefit a wide range of patients and healthcare professionals. For more information about the Society for Translational Oncology and its programs, please visit their website at sto-online.org.